Wound News and Research

RSS

Back injury can set you on your back and set you back financially

Whether you're doing heavy lifting as part of your "honey-do list" around the house or simply lifting groceries out of the car, a back injury can set you on your back (literally) and set you back financially. According to a tally of accident insurance claims submitted in 2009 to Colonial Life & Accident Insurance Company, back sprain or strain was the number-one occurring injury.

4 Mar 2010

Exposure to blue-violet light may enhance cell growth in wound sites

Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher C. Millan (U.S. Army Dental Corps, Martinez, Georgia) will present a poster of a study titled "A Novel In Vitro Model for Light-Induced Wound Healing."

4 Mar 2010

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.

2 Mar 2010

Unexplained, sudden anemia: Brown recluse spider bite

As spring approaches and people return to outdoor activities, caution should be taken in areas of the country that are home to Loxosceles reclusa, also called the brown recluse spider. A new study from St. Jude Children's Research Hospital found that when patients present with sudden anemia, but the cause is elusive, the brown recluse spider should be part of the differential diagnosis, at least in parts of the nation where the spider is regularly found.

27 Feb 2010

Article describing novel biological properties of Thymosin beta 4 peptide fragments published

REGENERX BIOPHARMACEUTICALS, INC. announced today that a university research team has published an article ahead of print in FASEB Journal, a high-impact scientific journal, describing novel biological properties of several Thymosin beta 4 (Tβ4) peptide fragments.

27 Feb 2010

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Wound Management Technologies, Inc. announced today that the recent increase in sales activities throughout the United States has resulted in 45 new clinicians evaluating their advanced wound care collagen product, CellerateRx® . In the last two months, these evaluations have transpired into new customers in Arizona, New Mexico, South Carolina, North Dakota, New Jersey, Wyoming, Colorado, and New York.

26 Feb 2010

Mutations in MeCP2 cause autism spectrum disorder Rett Syndrome

A paper published online today in Molecular Cell proposes that Methyl CpG binding protein 2 (MeCP2) impacts the entire genome in neurons, rather than acting as a regulator of specific genes. Mutations in MeCP2 cause the autism spectrum disorder Rett Syndrome as well as some cases of neuropsychiatric problems including autism, schizophrenia and learning disabilities.

26 Feb 2010

Translational Regenerative Medicine Forum in Winston-Salem

A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem.

25 Feb 2010

TWC, TSC announce the grand opening of new facilities at St. John’s Medical Plaza in Santa Monica

Tower Wound Care Center of Santa Monica and Tower Surgical Center are pleased to announce the grand opening of its new state-of-the-art facilities at St. John’s Medical Plaza in Santa Monica, California.

25 Feb 2010

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Virginia Life Science Investments, LLC and other investors have completed a recapitalization and management restructuring of Cupron, Inc., a Delaware corporation established in 2001, with principal offices in Modi’in, Israel. The transaction provides significant new capital to support the continued growth and development of Cupron Inc.; as well as the formation and initial capitalization of an independent new entity, Cupron Medical Inc., a Delaware corporation with principal offices in Richmond, VA.

25 Feb 2010

Synovis Life Technologies reports net revenue of $15.2M for first-quarter fiscal 2010

Synovis Life Technologies, Inc., today reported financial results for the first fiscal quarter ended Jan. 31, 2010.

24 Feb 2010

DSAEK cornea transplant offers potential long-term benefits

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty experienced greater cell loss overall compared to those who underwent penetrating keratoplasty, according to a new analysis of data collected from the Cornea Donor Study Investigator Group's 2008 Specular Microscopy Ancillary Study.

23 Feb 2010

Variations among individual organisms attributed to differences in genes, environment or chance

Biologists attribute variations among individual organisms to differences in genes or environment, or both. But a new study of nematode worms with identical genes, raised in identical environments, has revealed another factor: chance.

19 Feb 2010

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med’s proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.

18 Feb 2010

Medline Industries signs exclusive distribution agreement with Derma Sciences for BIOGUARD Barrier Dressings

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has signed an exclusive distribution agreement with Medline Industries for sales of one of its key products – BIOGUARD™ Barrier Dressing – into the acute care market. Medline is the 2nd leading provider of traditional wound care products into Acute Care facilities, with over 800 sales representatives. Sales will begin this month.

18 Feb 2010

New wound care teleassistance service launched

A new service is being launched today: wound care teleassistance, also known as téléassistance en soins de plaies (TASP). With this service a nurse can use a camera to film her patient's wound, while at the same time an expert nurse in another institution can receive the images. They can then hold an online discussion to evaluate the patient's wound and plan treatment.

18 Feb 2010

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

Derma Sciences, Inc., a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50.

17 Feb 2010

AP examines male circumcision efforts in Africa, including adult circumcision devices

The Associated Press examines efforts to prevent the spread of HIV by circumcising "about 50 million men across Africa - where 70 percent of the world's HIV-infected population lives."

17 Feb 2010

2010 WOCN/WCET Joint Conference focusing on patient care to be held in Phoenix

Healthcare professionals who specialize in wound, ostomy and/or continence care will have the opportunity to participate in a groundbreaking conference that combines the expertise of two premier wound, ostomy and continence associations, The Wound, Ostomy and Continence Nurses Society and The World Council of Enterostomal Therapists.

16 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Wound News and Research

Back injury can set you on your back and set you back financially

Exposure to blue-violet light may enhance cell growth in wound sites

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

Unexplained, sudden anemia: Brown recluse spider bite

Article describing novel biological properties of Thymosin beta 4 peptide fragments published

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Mutations in MeCP2 cause autism spectrum disorder Rett Syndrome

Translational Regenerative Medicine Forum in Winston-Salem

TWC, TSC announce the grand opening of new facilities at St. John’s Medical Plaza in Santa Monica

Virginia Life Science Investments completes recapitalization and management restructuring of Cupron

Synovis Life Technologies reports net revenue of $15.2M for first-quarter fiscal 2010

DSAEK cornea transplant offers potential long-term benefits

Variations among individual organisms attributed to differences in genes, environment or chance

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Medline Industries signs exclusive distribution agreement with Derma Sciences for BIOGUARD Barrier Dressings

New wound care teleassistance service launched

Derma Sciences announces pricing of public offering of 972,000 shares of its common stock

AP examines male circumcision efforts in Africa, including adult circumcision devices

2010 WOCN/WCET Joint Conference focusing on patient care to be held in Phoenix

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News